Tuesday, November 17, 2020
9:00am – Live Stream
Welcoming Remarks
9:05am – 9:50am – Live Stream
Comorbidities: When Diseases of Aging and Infection Converge
9:00am – 10:00am – On Demand
Emerging Company Showcase
Session 1A: CryoCrate LLC, Cytex Therapeutics, Inc, Diagnologix, Anschel Technology, Inc.
Session 1B: PHD Biosciences, Micronoma, KeViRx
9:00am – 4:00pm
Partnering Forum Open for Meetings
10:00am – 10:45am – Live Stream
Show Me The Money: Preparing Your Company for Funding
10:00am – 11:00am – On Demand
Emerging Company Showcase
Session 2A: Brevitest Technologies, LLC, Microvascular Therapeutics, LLC, Aqumin, Resurgence Biotechnologies
Session 2B: Mickey’s, Truvitech, ZBeats
11:00am – 12:00pm – On Demand
Emerging Company Showcase
Session 3A: Pain Care Labs (MMJ Labs), Orlance, Inc., Gypsy Basin Genomics, EVQLV
Session 3B: Cicero Diagnostics Inc, Pantherics Inc., HemoTag, Pacific Diabetes Technologies, Inc.,
11:00am – 11:30am – Live Stream
Special Presentation By Dr. Steven A. Rosenberg, Chief, Surgery Branch, National Cancer Institute
11:30am – 12:15am – Live Stream
Oncology Therapeutics, the Next Generation: Personalized Medicine, Scalability, Value Based Pricing, and Regulatory Issues.
12:15pm – Live Stream
Day One Recap
Wednesday, November 18, 2020
9:00am – Live Stream
Morning Remarks
9:00am – 9:50am – Live Stream
Proactive Approaches to Future Pandemics and Economic Viability:
The role of government, industry, and investment vehicles to support the continuous development of early stage, disruptive technologies and ventures to ensure health security
9:00am – 10:00am – On Demand
Emerging Company Showcase
Session 4A: Fairbanks Pharmaceuticals Inc, Goldilocks Therapeutics, Inc, Metaclipse Therapeutics, i-Cordis
Session 4B: BioIncept, LLC, SFC Fluidics, LLC, Sharper Sense, Optic Surg
Session 4C: IRIA Pharma, BLR Bio LLC
9:00am – 4:00pm
Partnering Forum Open for Meetings
10:00am – 10:45am – Live Stream
Fundraising 2021: Where Do We Go From Here?
10:00am – 11:00am – On Demand
Emerging Company Showcase
Session 5A: Avery Therapeutics, AxoSim, Inc, CMTx Biotech
Session 5B: Neuvotion, JelikaLite, Oligomerix, GoDx, Inc.